Singapore 7-9 December 2018 - PROGRAMME BOOK EXHIBITION GUIDE & - #ESTROASIA WWW.ESTRO.ORG
←
→
Page content transcription
If your browser does not render page correctly, please read the page content below
7-9 December 2018
PROGRAMME Singapore
BOOK
&
EXHIBITION
GUIDE
In scientific
collaboration
#ESTROASIA
with: WWW.ESTRO.ORG
7-9 December 2018
Singapore
ESTRO
European Society for Radiotherapy & Oncology
Rue Martin V, 40
1200 Brussels
Belgium
WWW.ESTRO.ORG
Table of contents
GENERAL INFORMATION 7
Welcome letter | 9
Scientific Programme Committee | 11
About ESTRO | 12
About FARO | 15
General information | 16
Acknowledgements | 18
SCIENTIFIC PROGRAMME 21
Friday 7 December 2018 | 22
Saturday 8 December 2018 | 31
Sunday 9 December 2018 | 40
POSTERS 43
Posters | 44
AWARDS 67
Poster awards - Supported by Mevion (Unrestricted educational grant) | 69
SATELLITE SYMPOSIA 71
Friday 7 December 2018 | 72
Saturday 8 December 2018 | 75
EXHIBITION AND COMMUNITIES PAVILION 79
Floorplan | 80
Exhibitors’ details | 82
National Societies’ details | 87
Programme and Exhibition Guide | TABLE OF CONTENTS 5
NOTES NOTES
GENERAL INFORMATION
Welcome letter 9
Scientific Programme Committee 11
About ESTRO 12
About FARO 15
General information 16
Acknowledgements 18
6 7Welcome letter
“ It is with great pleasure that we welcome you to the
first edition of the «ESTRO meets Asia» conference
in Singapore.
The «ESTRO meets Asia» conference has the
objective to bring radiation oncology collaboration
between Europe and Asia to a new level - regarding
Vincenzo Valentini Shyam Shrivastava
science, education, technology and professional
development, targeting all professionals working in
the discipline (clinicians, medical physicists, RTTs and radiobiologists).
The interactive conference format is designed to enable participants to share experiences
on practices/operations from both regions and discuss how to facilitate collaboration. The
conference will be a platform where participants will learn from each other by embracing
the diversity of clinical practices and exploring the development of common solutions to
optimise radiotherapy treatment and care for all patients.
The scientific programme, designed in collaboration with FARO and specialists from the
Asian region, will be made up of three components: an interdisciplinary component, a
radiobiology component and a component focusing on the practice of medical physicists
and RTTs.
The interdisciplinary component of the conference will offer teaching lectures, symposia
and proffered papers on the latest advancements on the topics of:
• Head and Neck (oropharynx)
• Rare tumours (lymphoma)
• Anal canal / rectal cancer
• Pelvic / gynaecological tumours
• Thorax (breast and lung cancer)
The radiobiology component will draw from the ESTRO Basic Radiobiology Course and
will cover mainly:
• A series of basic lectures introducing molecular and clinical radiobiology
• Mechanisms and models or radiation cell killing
• The linear-quadratic approach to fractionation
• Molecular basis of radiation response
• Radiobiology and tolerance of normal tissues to (re)treatment
8 Programme and Exhibition Guide | GENERAL INFORMATION 9Scientific Programme Committee
• Alternative fractionation schedules in radiotherapy Scientific Programme Committee (SPC)
• Tumour hypoxia and the microenvironment Chairs: Vincenzo Valentini (IT) and Shyam K. Shrivastava (IN)
• Combined radiotherapy and chemotherapy
• The volume and dose-rate effect in radiotherapy Members: Masahiro Hiraoka (JP), Gyorgy Kovacs (DE), Arie Munandar (ID), Jesper
• Biological response modifiers (tumours, normal tissues) and molecular approaches to Eriksen (DK), Sandra Turner (AU), Michelle Leech (IE), Gurvinder Singh Wadhawan
therapy (IN), Dirk Verellen (BE), Natalka Suchowerska (AU)
• Protons and other particles in radiotherapy
• Radiation-induced malignancies.
Abstract Reviewers
The third component of the conference is focusing on the practice of medical physicists and Appari, Sridhar, Mr. (IN); Aznar, Marianne, Dr. (GB); Baggarley, Shaun, Mr. (SG);
RTTs and will cover topics such as: Bilimagga, Ramesh, Prof. (IN); Boejen, Annette (DK); Chalmers, Anthony, Prof. Dr.
• IGRT, patient positioning and immobilisation (GB); Chitapanarux, Imjai, Dr. (TH); Chopra, Supriya, Dr. (IN); CHOUGULE, ARUN,
• Dosimetry, audit and risk assessment Prof. Dr. (IN); Coffey, Mary (IE); Coppes, Robert, Prof. Dr. (NL); Eriksen, Jesper Grau,
• Brachytherapy Prof. Dr. (DK); Franco, Pierfrancesco, Dr. (IT); Grégoire, Vincent, Prof. (FR); Hiraoka,
Masahiro, Dr. (JP); Hoskin, Peter, Prof. (GB); Hurkmans, Coen, Dr. (NL); Joiner,
Michael, Prof. (US); Jornet, Núria, Dr. (ES); Khoo, Vincent, Dr. (GB); Kim, Hyun Ju, Dr.
The conference will also include round table discussions on the organisation of education, (KR); Kinhikar, Rajesh, Mr. (IN); Kodrat, Henry, Dr. (ID); Kovács, György, Prof. Dr.
training and certification as well as sessions linked to ongoing projects such as HERO (DE); Krisanachinda, Anchali, Dr. (TH); Lara Jimenez, Pedro Carlos, Prof. (ES); Lassen,
(Health Economics in Radiation Oncology); GTFRCC (Global Task Force on Radiotherapy Pernille, Dr. (DK); Lee, Kar-ho Francis, Dr. (HK); Leech, Michelle (IE); Leong, Aidan
for Cancer Control) and GIRO (Global impact of radiotherapy in oncology) under the (NZ); Mahantshetty, Umesh, Dr. (IN); Marignol, Laure, Dr. (IE); Mast, Mirjam (NL);
overall umbrella of advocacy. Mel, Mora, Dr. (KH); Munandar, Arie, Dr. (ID); Oguchi, Masahiko, Dr. (JP); Ohno,
Tatsuya, Prof. Dr. (JP); Prajogi, Gregorius Ben, Dr. (ID); Rasch, Coen, Prof. Dr. (NL);
Ricardi, Umberto, Prof. (IT); Sharma, Daya Nand, Prof. (IN); Shirato, Hiroki, Prof. (JP);
ESTRO and FARO look forward to your active participation in this conference. Slotman, Ben, Prof. Dr. (NL); Suchowerska, Natalka, Dr. (AU); Suh, Tae-Suk, Dr. (KR);
Sun Myint, Arthur, Prof. (GB); Swamidas, Jamema, Mrs. (IN); Tham, Ivan, Dr. (SG);
Thorwarth, Daniela, Dr. (DE); Trainor, Glenn, Mr. (AU); Tsang, Yat Man (GB); Turner,
Vincenzo Valentini and Shyam Shrivastava Sandra, Dr. (AU); Uchida, Nobue, Dr. (JP); Valentini, Vincenzo, Prof. (IT); Verellen,
ESTRO meets Asia Scientific Programme Committee Chairs Dirk, Prof. (BE); Wadhawan, Gurvinder Singh (IN); Wong, Sharon (SG); Wong, Tony, Dr.
(US); Yi, Junlin, Dr. (CN);
”
10 GENERAL INFORMATION | Programme and Exhibition Guide Programme and Exhibition Guide | GENERAL INFORMATION 11About ESTRO
ESTRO Vision 2030 • Live and online workshops courses with FALCON (Fellowship in Anatomic deLineation
The governance of ESTRO is pleased to share with you the 2030 vision that has been officially and CONtouring), the online delineation programme
presented at ESTRO 37 in Barcelona last April. • Hands-on experience through mobility grants programme.
The ESTRO School promotes multidisciplinary education in oncology, basic science, physics
and technology, imaging, and interdisciplinary oncology, with the objective of standardising
knowledge and clinical practice, whilst recognising the diversity of radiation oncology
practice in different parts of the world. In 2019, the ESTRO School is organising 41 live
courses (33 in Europe and 6 outside Europe) and 2 undergraduate courses.
More information on the 2019 course programme on www.estro.org
ESTRO Conferences
The 2030 vision will set the roadmap to follow for the further development of the discipline ESTRO next annual conference:
of radiation oncology.
ESTRO 38
26-30 April 2019 | Milan, Italy
ESTRO Mission ESTRO 38 will focus on the latest data in clinical oncology, radiation physics, radiation
Founded in 1980, ESTRO is a non-profit scientific organisation whose role is to foster, in all technology and patient’s care, brachytherapy and radiobiology, all contributing to the
its aspects, radiation oncology, clinical oncology and related subjects, including physics as ultimate goal: a better patients’ outcome in cancer treatment.
applied to radiotherapy, radiation technology and radiobiology.
To fulfill its purpose, ESTRO promotes education, science, research and advocate for access
ESTRO Membership
to radiotherapy through its teaching courses, workshops, meetings, publications and public
The ESTRO memberships gathers 7,300 professionals of radiation oncology and its related
affairs activities.
fields, providing them with the resources and tools they need to successfully support their
career development.
ESTRO School ESTRO members can benefit from a host of advantages such as:
The ESTRO School has become an internationally recognised provider of high quality • Online subscription to Radiotherapy & Oncology, the Society’s journal
education in radiotherapy and oncology and has developed a wide array of educational • Reduced fees for attending ESTRO conferences, teaching courses and online workshops
activities: • Online access to scientific material through the e-library (DOVE)
• Live teaching courses covering basic and continuing medical educational needs of all • Eligibility for grants, awards, faculties and governance positions.
professionals working in the field of (radiation) oncology
• Pre-meeting teaching courses, workshops, teaching lectures and tumour boards during A wide range of oncology professions are represented within the ESTRO community:
congresses radiation oncologists, clinical oncologists, medical physicists, radiobiologists, radiation
12 GENERAL INFORMATION | Programme and Exhibition Guide Programme and Exhibition Guide | GENERAL INFORMATION 13About FARO
therapists (RTTs), dosimetrists, radiotherapy nurses, medical oncologists, surgeons, The Federation of Asian Organizations for Radiation Oncology (FARO) was founded in 2014
industry representatives, organ specialists, other medical and non-medical professions, as a non-profit and scientific organization. FARO is intended to function as a federation
coming from more than 100 countries spread all over the world. of radiation oncology societies in Asia and aims to foster the role of radiation oncology to
improve the basic level of radiotherapy for the benefit of the patients in the Asian region.
More information on www.estro.org
Asia is a major part of the global community (more than 50% of the world population) and
at the same time the most heterogeneous and diverse region. FARO has 12 member societies
(the national radiation oncology societies from Bangladesh, China, India, Indonesia, Japan,
ESTRO Publications
South-Korea, Malaysia, Philippines, Singapore, Sri Lanka, Thailand and Pakistan) and plans
Radiotherapy & Oncology to continue to grow bigger and stronger as time goes by.
Radiotherapy & Oncology, the Green Journal, is the flagship publication in ESTRO’s family
of journals. The Journal publishes original research articles and review articles on all aspects The mission of FARO is to promote innovation, research, and dissemination of science and
of radiation oncology and has a current impact factor of 4,328. technology through its congresses, special meetings, educational courses and publications.
The aims and purposes of the Federation are :
www.thegreenjournal.com
1. To promote the co-operation and communication between Radiation Oncology
Organizations in the region
Open access journals
2. To develop the standard of education/training and research irradiation oncology and
ESTRO and Elsevier have launched more recently three new open access journals in order to
related field in the region
provide specialised venues for the publication of ESTRO members’ work:
3. To promote the advancement in status and standard of practice of the radiation oncology
• Clinical and Translational Radiation Oncology – ctRO, www.ctro.science
profession
• Physics and Imaging for Radiation Oncology – phiRO, www.phiro.science
4. To organize and/or sponsor international conferences, regional and other meetings or
• Technical Innovations and Patient Support in Radiation Oncology – tipsRO, www.tipsro.
courses
science
5. To collaborate or affiliate with other scientific or professional Organizations.
FARO has organised 3 meetings so far:
• Kyoto (JP), 25-27 November 2016
• Bangalore (IN), 9-10 November 2017
• Bali (Indonesia) 6-8 September 2018
The following officers are currently representing the FARO Council:
• President .............................................. Soehartati GONDHOWIARDJO (IROS)
• Vice President ..................................... Ivan THAM (SRS)
• Secretary General .............................. Takashi NAKANO (JASTRO)
• Treasurer ............................................. Xianshu GAO (CSRO)
• President Elect .................................... Shyam SHRIVASTAVA (AROI)
• Deputy Secretary Gen. ...................... Tomoaki TAMAKI (JASTRO)
14 GENERAL INFORMATION | Programme and Exhibition Guide Programme and Exhibition Guide | GENERAL INFORMATION 15General information
Venue Official language
Singapore Expo The official language of the congress is English. No simultaneous translation will be provided.
Max Atria entrance
1 Expo Dr, Singapore 486150
Posters
Posters will be displayed in the poster area during the conference.
Accommodation
SINGEXPRESS TRAVEL DMC
Ms Florence Cheong / Ms Janet Chee Satellite symposia
Tel.: +65 6823 1605 (Monday to Friday during Singapore time 09.00 to 18.00 hrs) Commercial satellite symposia will be held during lunch breaks.
Email: events@singexpress.com.sg
Currency
The currency in Singapore is the Singapore dollar.
Exhibition
An exhibition featuring medical devices and services will be held in the exhibition area. The
opening of the exhibition will be on Friday 7 December 2018 at 9.30 hrs. The exhibition will
remain open from Friday 7 December to Sunday 9 December included. Entrance is free for
all registered participants and registered visitors.
Luncheon and refreshments
The registration fee for the conference includes coffee breaks and lunch to all participants
and exhibitors wearing their conference badges.
Networking evening
A networking evening will be held in the exhibition area on Friday 7 December at the end
of the session day.
16 GENERAL INFORMATION | Programme and Exhibition Guide Programme and Exhibition Guide | GENERAL INFORMATION 17Acknowledgements
ESTRO would like to extend a special thank you to the ESTRO Meets Asia Scientific Program
Committee for having accepted the responsibility to develop the scientific program and for
their valuable contribution to the conference.
18 GENERAL INFORMATION | Programme and Exhibition Guide Programme and Exhibition Guide | GENERAL INFORMATION 19NOTES NOTES
SCIENTIFIC PROGRAMME
Friday 7 December 2018 22
Saturday 8 December 2018 31
Sunday 9 December 2018 40
20 21Friday 7 December 2018
FRIDAY 7 DECEMBER 2018
FRIDAY 7 DECEMBER 2018
TEACHING LECTURE
Cell death mechanisms, cell & tissue survival assays
09:30 - 10:30 | ROOM TOPAZ
09:30 > Speaker: E. Hau (Australia) SP-007
OPENING CEREMONY
Opening Ceremony
08:00 - 08:30 | ROOM GARNET 213 ROUNDTABLE PANEL DISCUSSION
Dose Planning (up to IMRT)
09:30 - 10:30 | ROOM GARNET 212
TEACHING LECTURE
DNA damage and repair, chromosome damage, checkpoints Moderator: D. Verellen (Belgium)
08:30 - 09:30 | ROOM TOPAZ Panellists: S. Alim (Bangladesh), A.Boejen (Denmark),
N. Chatchaipaibon (Thailand), K.J.Park (Australia),
08:30 > Speaker: A. Potter (Australia) SP-001 P. Ravindran (India), J. Swamidas (India), T. Wong (USA)
TEACHING LECTURE SYMPOSIUM
From 2D to IMRT: technology, treatment planning, delivery and QA Putting knowledge in practice: Oropharynx
08:30 - 09:30 | ROOM GARNET 212 09:30 - 10:30 | ROOM GARNET 213
Chairs: N. Suchowerska (Australia) and M. Leech (Ireland) Chairs: J.G. Eriksen (Denmark) and S. Gondhowiardjo (Indonesia)
08:30 > From 2D to 3DCRT to IMRT 09:30 > Is HPV related oropharyngeal cancer more chemo-radiosensitive than
Speaker: T. Wong (USA) SP-002 HPV negative OPC in Chinese patients?
08:50 > Changing paradigms in RTT practice from 2D to ART Speaker: X. Wang (China) SP-008
Speaker: M. Kamphuis (The Netherlands) SP-003
09:50 > Concomitant Chemotherapy in HPV+ patients in IMRT era
09:10 > Introducing advanced technologies: the reality Speaker: J. Bourhis (Switzerland) SP-009
Speaker: P. Ravindran (India) SP-004
10:10 > How to deal with nodal involvement in OPC
Speaker: V. Grégoire (France) SP-010
TEACHING LECTURE
Head and Neck – Oropharynx
08:30 - 09:30 | ROOM GARNET 213 TEACHING LECTURE
Chair: V. Grégoire (France) Cell survival & models - intro to LQ
11:00 - 12:15 | ROOM TOPAZ
08:30 > Hypoxia: a potential target in radiotherapy for H&N cancer
and its perspective 11:00 > Speaker: M. Joiner (USA) SP-011
Speaker: M. Miura (Japan) SP-005
09:00 > Adaptive Two-step Intensity Modulated Radiation Therapy (IMRT) for
Oropharyngeal Cancer
Speaker: Y. Nishimura (Japan) SP-006
22 SCIENTIFIC PROGRAMME | Programme and Exhibition Guide Programme and Exhibition Guide | SCIENTIFIC PROGRAMME 23FRIDAY 7 DECEMBER 2018
FRIDAY 7 DECEMBER 2018
PROFFERED PAPERS 1 PROFFERED PAPERS 1
Dose planning and verification (Physics) H&N, Haematology, Gynaecology (Clinical)
11:00 - 12:15 | ROOM GARNET 212 11:00 - 12:15 | ROOM GARNET 213
Chairs: J. Shakeshaft (Australia) and R. Kinhikar (India) Chairs: J. Bourhis (CH), TBC
11:00 >
Analysis of Newer Treatment Techniques in High Grade Glioma: 11:00 >
Long-term report of total marrow or total lymphoid IMRT in advanced
VMAT Versus IMRT Versus 3DCRT leukemia, myeloma and lymphoma
V. Pareek, R. Bhalavat, M. Chandra, P. Bauskar (India) OC-012
S. Vagge, A. Dominietto, F. Guolo, A.M. Carella, R.M. Lemoli,
A. Bacigalupo, E. Angelucci, R. Corvò (Italy) OC-019
11:10 >
Dosimetric comparison of breath hold and free breathing technique in
stereotactic body radiotherapy 11:10 > The value of prognostic nutritional index in follicular lymphoma
K.R. Mani, R. Lingaiah, M.M. Alam, M.A. Bhuiyan, K.A. Haque, S.F. Lee, T.Y. Ng, F.C.S.Wong (Hong Kong (SAR) China) OC-020
S. Ahmed, M.A. Sumon, S. Basu, A.K. Sengupta, M.R.U. Nabi,
S. Chadhuri (Bangladesh) OC-013 11:20 > IMRT plus S-1 chemotherapy in locally advanced nasopharyngeal
carcinoma:a multicenter phase II study
11:20 >
Evaluation of a New Commercial Automated Breast Planning Software: X. Wang, T. Lv, Y. Wang, L. Liu, P. Lou, S. Qin (China) OC-021
A first experience in Japan
N. Mizuno, R. Yamauchi, S. Fukushima, S. Kashiyama, T. Itazawa, 11:30 >
A phase II study about locally advanced NPC treated with CCRT
J. Kawamori (Japan) OC-014 followed with metronomic chemotherapy
M. Feng, J. Lang, Y. Gao, B. Fu, L. Li, Y. Huang, P. Xu, Y. Qi, K. Xu,
11:30 >
Dosimetric Influence of Jaw tracking in IMRT and VMAT for J. Yin, S. Wang, M. Lan, S. Lu (China) OC-022
Carcinoma of Cervix
M.A. Muneem, N. Sultana, T. Hossain, T. Basharat, K.R. Mani (Bangladesh) OC-015 11:40 >
Whole pelvis intensity-modulated radiation therapy with central-
shielding for cervical cancer
11:40 >
Commissioning and validation of deformable image registration (DIR)
Y. Mukai, A. Sato, H. Inoue, Y. Tayama, K. Matui, T. Fukuda, K. Onuma,
software using AAPM TG132 T. Inoue, M. Hata, M. Omura (Japan) OC-023
R. Phurailatpam, K. Joshi, D. Deshpande, J. Sv (India) OC-016
11:50 >
CT-DNA as screening and predictive marker in cervical cancer
11:50 >
Personalising Lung Radiation Therapy: Optimising VMAT Planning patients receiving radiotherapy
with Functional Lung Imaging
J. Yang, M. Fan, J. Wang, J. Wang, M. Chen, L. Pan, L. Sun (China) OC-024
N. Bucknell, N. Hardcastle, S. Prasad, D. Ball, T. Kron, S. Siva (Australia) OC-017
12:00 >
Evaluating the Risk of Normal Tissue Toxicity Using DNA Repair
12:00 >
Dosimetric comparison of Flattened and Un-flattened Beams for Brain and Genetic Variant Analysis
Lesions
K.D. Mumbrekar, H.V. Goutham, K. Sharan, B.S.S. Rao (India) OC-025
P.K. Mani, S. Paulpandi, K. Vittal, K. Bayyareddygari,V. Manoor Ural,
N. Veeraragavan, V.R. Subramanian, C.A. Radha (India) OC-018
24 SCIENTIFIC PROGRAMME | Programme and Exhibition Guide Programme and Exhibition Guide | SCIENTIFIC PROGRAMME 25FRIDAY 7 DECEMBER 2018
FRIDAY 7 DECEMBER 2018
POSTER VIEWING 1 TEACHING LECTURE
Dose planning and verification (RTT) IGRT and treatment verification
11:00 - 12:15 | POSTER AREA 13:45 - 14:45 | ROOM GARNET 212
Chairs: A. Boejen (Denmark) and K.J. Park (Australia) Chairs: D. Montgomerie (New Zealand) and TBC
11:00 >
Treating left breast cancers with ABC device without patient selection 13:45 > Image Guided Application in Radiation Therapy
criteria and coaching Speaker: T. Suk Suh (Korea Republic of) SP-033
C.Y. Koh, J. Tang (Singapore) PV-026
14:05 > The role of functional imaging in guiding radiation therapy
11:12 >
Dosimetric comparison of craniospinal Irradiation by TomoDirect, Speaker: M. Aznar (United Kingdom) SP-034
TomoHelical and 3D conventional RT
S.W.S. Tsang, G. Chiu, J.T.L. Wong, M. Collins (Hong Kong (SAR) China) PV-027 14:25 > Optimising image verification procedures at the treatment console
Speaker: A. Leong (New Zealand) SP-035
11:24 >
Free Breathing versus Deep Inspiration Breath-Hold OAR Doses in
Breast Cancer
P. Gamre, K. Chauhan, U. Gaikwad, R. Phurailatpam, T. Wadasadawala, TEACHING LECTURE
R. Sarin (India) PV-028 Rare Tumors
13:45 - 14:45 | ROOM GARNET 213
11:36 >
Analysis of 6MV FB versus 6MV UF photon beam treatment planning
Chair: M. Hiraoka (Japan)
and delivery by IMRT technique
T. Suresh, S. Madeswaran, Y. Girigesh, S. Kothanda Raman, G. Munish,
13:45 > CNS Pediatric Tumors: Clinical trials, technologies and outcome
D. Abhinav (India) PV-029
Speaker: U. Ricardi (Italy) SP-036
11:48 >
Comparison of Hybrid-VMAT technique using two treatment planning
14:15 > Sarcoma(s) and brachytherapy: technologies and outcome
systems for esophageal cancer
Speaker: S. Laskar (India) SP-037
M. Miyazaki, Y. Ueda, S. Ohira, M. Isono, A. Masaoka, S. Inui,
T. Teshima (Japan) PV-030
12:00 >
Dosimetric error factor in radiosurgery for brain mets using the single TEACHING LECTURE
isocenter technique Normal tissue response and mechanisms
Y. Sonoda, M. Akimoto, S. Itasaka, K. Kondou (Japan) PV-031 14:45 - 15:45 | ROOM TOPAZ
14:45 > Speaker: A.Van der Kogel (USA) SP-038
TEACHING LECTURE
Dose response, therapeutic ratio
13:45 - 14:45 | ROOM TOPAZ ROUNDTABLE PANEL DISCUSSION
IGRT and beyond
13:45 > Speaker: M. Joiner (USA) SP-032 14:45 - 15:45 | ROOM GARNET 212
Moderator: T. Wong (USA)
Panellists: M. Aznar (United Kingdom), A. Leong (New Zealand),
T. Suk Suh (Korea Republic of), D. Verellen (Belgium), S. Wong (Singapore),
J. Yuen (Australia)
26 SCIENTIFIC PROGRAMME | Programme and Exhibition Guide Programme and Exhibition Guide | SCIENTIFIC PROGRAMME 27FRIDAY 7 DECEMBER 2018
FRIDAY 7 DECEMBER 2018
SYMPOSIUM 17:03 >
Initial validation of dose calculation accuracy on Hounsfield
Putting knowledge at work in Lymphoma Unit-corrected pelvic cone beam CT
14:45 - 15:45 | ROOM GARNET 213
G. Bengua, S. Lydiard, J. Sandison, S. Andersson, R. Nilsson (New Zealand) OC-047
Chairs: Y. Lievens (Belgium) and B.Vellayappan (Singapore)
14:45 > Modern therapeutic approaches in lymphoma: when RT is mandatory? PROFFERED PAPERS 2
Speaker: U. Ricardi (Italy) SP-039 Upper GI and thorax (Clinical)
16:15 - 17:30 | ROOM GARNET 213
15:05 > Lymphoma and doses: when and how much is safe to reduce them Chairs: B. Slotman (The Netherlands) and I. Tham (Singapore)
Speaker: M. Oguchi (Japan) SP-040
15:25 > Lymphoma and volumes: when and how much is safe to reduce them 16:15 >
Exclusive dose-escalated chemoradiotherapy in esophageal carcinoma:
Speaker: A. Wirth (Australia) SP-041 a randomized phase II study
G. Crehange, A. Bertaut, E. Le Prisé, P.L. Etienne, E. Rio, R. Pereira,
G. Noel, K. Benezery, D. Peiffert (France) OC-048
TEACHING LECTURE 16:25 >
Retrospective study of adjuvant chemoradiotherapy for R0 resected
Tumour radiobiology and kinetics patients with pN3 gastric cancer
16:15 - 17:30 | ROOM TOPAZ
M.L. Zhou, Y.Q. Wang, W. Yang, M. Mo, R. Hu, Y. Wang, G.C. Li,
Z.W. Long, X.W. Liu, Y.N. Wang, Z. Zhang (China) OC-049
16:15 > Speaker: A. Potter (Australia) SP-042
16:35 > Quality of life for gemcitabine+nab-paclitaxel+SBRT
vs. gemcitabine+S-1+SBRT in pancreatic cancer
PROFFERED PAPERS 2 X. Zhu, Y. Cao, Y. Shen, S. Qing, F. Cao, L. Gu, F. Fang, Z. Jia, X. Ju,
IGRT and treatment verification (RTT) H. Zhang (China) OC-050
16:15 - 17:30 | ROOM GARNET 212
Chairs: A. Leong (New Zealand) and A. Sridhar (IN) 16:45 >
Acute toxicity of hypofractionated radiation with simultaneous bed
boost in breast cancer patients
16:15 >
Development of the twist-correction system for radiotherapy of head
J. Luo, K. Jin, X. Wang, Z. Yang, J. Ma, X. Chen, X. Mei, X. Guo,
and neck cancer patients X. Yu (China) OC-051
H. Shimizu, K. Sasaki, T. Aoyama, S. Matsushima, T. Isomura, 16:55 >
Clinical outcomes of triple negative breast cancer : a single institution
T. Kitagawa, H. Fukuma, H. Tachibana, T. Kodaira (Japan) OC-043
study
16:27 >
Clinical Analysis of Geometric Accuracy using On-Board Imager
S. Ibrahim, A. Arjunan, P. Balakrishnan, B.S. Mathew, R.K. Raghavan,
in Radiotherapy K. Ramadas (India) OC-052
S.S. Tomar, M. Gairola, G. Yadav, G. Wadhawan (India) OC-044
17:05 >
A prognostic model for non-lung-cancer death in old patients treated
16:39 > Is surface imaging a reliable target indicator for pelvic radiation therapy? with SBRT for lung cancer
R. Chua (Australia) OC-045
Y. Matsuo, T. Mitsuyoshi, T. Shintani, T. Mizowaki (Japan) OC-053
16:51 >
Simple management system of kV imaging doses during image-guided 17:15 > Improving lung cancer outcome by reducing normal lung tissue toxicity
radiotherapy Abstract withdrawn OC-054
J. Miyata, M. Akimoto, M. Kuroda, M. Oita, K. Kondo, S. Itasaka (Japan) OC-046
28 SCIENTIFIC PROGRAMME | Programme and Exhibition Guide Programme and Exhibition Guide | SCIENTIFIC PROGRAMME 29Saturday 8 December 2018
FRIDAY 7 DECEMBER 2018
SATURDAY 8 DECEMBER 2018
POSTER VIEWING 2
IGRT and treatment verification (Physics)
16:15 - 17:30 | POSTER AREA
Chairs: K.R. Mani (Bangladesh) and TBC
16:15 >
Dosimetric impact of intrafraction rotations in stereotactic prostate TEACHING LECTURE
radiotherapy. Fractionation and overall time
J. Wolf, J. Nicholls, P. Hunter, D. Trang, P. Keall, J. Martin (Australia) PV-055 08:00 - 09:00 | ROOM TOPAZ
16:24 >
Dosimetric impact of uniform versus differential prostate bed expansion
margins utilising IGRT 08:00 > Speaker: E. Hau (Australia) SP-064
E. Grierson, D. Wilkinson, L. Bell, J. De Leon (Australia) PV-056
16:33 >
Rigid and Deformable Image Registration Practice Pattern: TEACHING LECTURE
International Results Quality management
J. Yuen, A. Ralston, A. Gray, A. Walker, M. Jameson, N. Hardcastle, 08:15 - 09:15 | ROOM GARNET 212
L. Schmidt, K. Harrison, J. Poder, J. Sykes, J. Barber (Australia) PV-057 Chairs: J. Lye (Australia) and W. Hoy (Singapore)
16:42 > Retrospective analysis of prostate movement using Gold fiducial markers
08:15 > RT dosimetry yesterday, today and tomorrow
J. Aathilakshmi, P.K. Mani, S. Paulpandi, K. Bayyareddygari, K. Vittal,
Speaker: M. Nakamura (Japan) SP-065
N. Veeraragavan, V. Manoor Ural (India) PV-058
08:35 > Quality management in treatment delivery
16:51 >
A modular quality management program for image registration with
Speaker: M. Coffey (Ireland) SP-066
a risk-based approach
J. Yuen, L. Schmidt, R. Brown, J. Poder, A. Ralston (Australia) PV-059 08:55 >
Safe and rapid implementation of radiotherapy technologies
and techniques: the RABBIT system
17:00 > Dosimetric characteristics of INTRABEAM using spherical applicators
Speaker: A. Ralston, J. Yuen (Australia) SP-067
ABSTRACT WITHDRAWN PV-060
17:09 >
Skin Dosimetry of Patient-tailored 3D-printed Bolus Application in
Post-mastectomy Electron Beam RT TEACHING LECTURE
S. Seol, J. Shin, W. Park, K. Yang, S. Ju, D. Choi, H. Cha, Perineum
H. Cho (Korea Republic of) PV-061 08:00 - 09:00 | ROOM GARNET 213
Chair: S.K. Shrivastava (India)
SYMPOSIUM 08:00 > Anal canal: technologies and outcome
Health Economics in Radiation Oncology (HERO) Speaker: P. Franco (Italy) SP-068
17:30 - 18:15 | ROOM GARNET 213
08:30 > Vulvar cancer: technologies (EBRT, brachytherapy) and outcome
Chairs: M.J. Calaguas (Philippines) and U.Ricardi (IT)
Speaker: D.N. Sharma (India) SP-069
17:30 > ESTRO-HERO: Introduction and background
Speaker: B. Slotman (The Netherlands) SP-062
17:45 > Where are we now and where are we heading?
Speaker: Y. Lievens (Belgium) SP-063
30 SCIENTIFIC PROGRAMME | Programme and Exhibition Guide Programme and Exhibition Guide | SCIENTIFIC PROGRAMME 31SATURDAY 8 DECEMBER 2018
SATURDAY 8 DECEMBER 2018
TEACHING LECTURE PROFFERED PAPERS 3
Oxygen effect, sensitizers, microenvironment Quality management and verification (Physics)
09:00 - 10:15 | ROOM TOPAZ 10:45 - 12:00 | ROOM GARNET 212
Chairs: D. Verellen (Belgium) and TBC
09:00 > Speaker: A. Van der Kogel (USA) SP-070 10:45 >
Single institutional experience of TRS483 for small static fields used
in external beam radiotherapy
K.R. Mani (Bangladesh) OC-075
ROUNDTABLE PANEL DISCUSSION
10:55 >
Australian Dosimetric Benchmarking in Radiation Oncology Audit:
Quality management
A Driver for Improved Treatment
09:15 - 10:15 | ROOM GARNET 212
A. Alves, C. Davey, F. Kadeer, J. Kenny, M. Shaw, J. Supple, J. Lye (Australia) OC-076
Moderator: N. Suchowerska (Australia) 11:05 > Calibration and characterization of CBCT for dose calculation
Panellists: Jessica Lye (Australia), M. Coffey (Ireland), M. Nakamura (Japan), Y.I. Tan, Y.F. Leong, J.F. Loria Cruz, S. Baggarley (Singapore) OC-077
A. Ralston (Australia), T. Wong (USA), James C L Lee (SG)
11:15 >
Re-irradiation with SBRT for pancreatic cancer: dose summation
and toxicity
SYMPOSIUM
X. Zhu, Y. Cao, F. Cao, S. Qing, Y. Shen, L. Gu, F. Fang, Z. Jia, X. Ju,
Rectum H. Zhang (China) OC-078
09:00 - 10:15 | ROOM GARNET 213 11:25 >
Comparing manual and automatic planning based on optimal
Chairs : E. Zubizarreta (Austria) and Y. Nagata (Japan) parameters in Rapidplan for ESO cancer
C. Ling, P. Zhai (China) OC-079
09:00 > Personalised delineation in rectal cancer
Speaker: P. Franco (Italy) SP-071 11:35 >
Monte Carlo calculation of kQ factors in modulated and unmodulated
proton beams
09:25 > Preoperative radiotherapy: where we stand
C. Gomà (Belgium) OC-080
Speaker: V. Valentini (Italy) SP-072
11:45 >
A multi-modality end-to-end audit for measuring conformal
09:50 > Brachytherapy: where we stand and IMRT/VMAT radiotherapy
Speaker: A. Sun Myint (United Kingdom) SP-073
J. Lye, A. Alves, C. Davey, F. Kadeer, J. Kenny, M. Shaw, J. Supple (Australia) OC-081
TEACHING LECTURE PROFFERED PAPERS 3
LET, RBE, particles Lower GI and radiomics (Clinical)
10:45 - 12:00 | ROOM TOPAZ 10:45 - 12:00 | ROOM GARNET 213
Chairs: Takashi Nakano (Japan) and R. Engineer (India)
10:45 > Speaker: A. Potter (Australia) SP-074
10:45 >
Long-course NACRT vs short course RT(5*5GY) plus consolidation CT
with delayed surgery in CA rectum
N. Thakur (India) OC-082
32 SCIENTIFIC PROGRAMME | Programme and Exhibition Guide Programme and Exhibition Guide | SCIENTIFIC PROGRAMME 33SATURDAY 8 DECEMBER 2018
SATURDAY 8 DECEMBER 2018
10:55 > Good prognostic value of increased lymph node yield in rectal cancer 11:05 >
Evaluation of Inter fraction and Intra fraction motion in head and
with neoadjuvant chemoradiation neck Malignancy
Y. Wang, M. Zhou, J. Zhang, L. Yang, L. Shen, L. Liang, Z. Zhang (China) OC-083
M. Sharma, A. Bahl, A.S. Oinam, A. Elangovan, R. Miriyala, C. Dracham,
S. Ghoshal (India) PV-091
11:05 >
The Predictive and Prognostic Significance of SFRP2 in Locally
Advanced Rectal Cancer Patients 11:15 >
Determination angles of breast board in 100 patients undergoing RT
J. Zhang, L. Shen, Y. Wang, X. Sun, Y. Deng, Z. Zhang, W. Zou, H. Zhang, in CA breast with tangents
L. Yang, J. Wan, F. Xia, J. Zhu, Z. Zhang (China) OC-084
A. Singh, G. Rath, H. Singh (India) PV-092
11:15 >
Externally validated nomogram for response prediction based on immune 11:25 > New Zealand radiation therapist’s perceptions of peer group supervision
inflammation in anal cancer G. Dungey, H. Neser (New Zealand) PV-093
P. Franco, F. Arcadipane, G. Iorio, F. Olivero, V. Chiofalo, F. Montagnani,
D. Aloi, A. Casadei Gardini, B. De Bari, S. Cascinu, U. Ricardi (Italy) OC-085 11:35 >
Implementation of Quality Audit (QA) in Clinical Radiotherapy Units i
n HCG in India-A Report
11:25 >
Radiomics for response prediction in hybrid MR guided RT:
M. Pundalika, R. Bilimagga (India) PV-094
generating hypothesis in rectal cancer
L. Boldrini, D. Cusumano, C. Masciocchi, F. Cellini, G. Chiloiro, C. Casà,
N. Dinapoli, L. Azario, M.A. Gambacorta, M. De Spirito, V. Valentini (Italy) OC-086 SYMPOSIUM
Global Impact of Radiotherapy in Oncology (GIRO)
11:35 >
A Radiogenomics Framework to Improve Prediction of Clinical
12:00 - 12:45 | ROOM GARNET 213
Outcomes in Esophageal Cancer
Chairs: U. Ricardi (Italy) and R.R. Prasad (India)
X. Li, P. Yang, Y. Kuang, T. Niu, S. Wu (China) OC-087
11:45 >
Planning CT-based radiomics can differentiate grade 2 from grade 3 12:00 > From GTFRCC to GIRO
soft tissue sarcomas Speaker: Y. Lievens (Belgium) SP-095
J.C. Peeken, M. Bernhofer, M.B. Spraker, D. Pfeiffer, A. Thamer,
12:15 > Hypofractionation: insight into world-wide patterns-of-care
M. Shouman, F. Nüsslin, N.A. Mayr, B. Rost, M.J. Nyflot,
Speaker: D. Rodin (Canada) SP-096
S.E. Combs (Germany) OC-088
12:30 > How to ascertain sustainability of radiotherapy
Speaker: E.H. Zubizarreta (Austria) SP-097
POSTER VIEWING 3
Quality management and verification (RTT) TEACHING LECTURE
10:45 - 12:00 | POSTER AREA Volume effects, retreatment
Chairs: M. Coffey (Ireland) and G.S. Wadhawan (India) 14:15 - 15:15 | ROOM TOPAZ
10:45 >
Comparison of two immobilization devices used for treatment of breast and 14:15 > Speaker: A. Van der Kogel (USA) SP-098
abdomen regions
P. Umbarkar, S. Deshpande, S. Naidu, S. Shinde, N. Parmar, J. Ashiwini,
P. Kamble, S. Ullagaddi, O. Jadhav, K. Venkatesan, V. Anand, R. Bajpai,
V. Babu, V. Mittal (India) PV-089
10:55 > Setup errors in brain tumor patients with ET and CBCT Imaging
P. Nayyar, R.K. Munjal, D. Kumar, M. Simar (India) PV-090
34 SCIENTIFIC PROGRAMME | Programme and Exhibition Guide Programme and Exhibition Guide | SCIENTIFIC PROGRAMME 35SATURDAY 8 DECEMBER 2018
SATURDAY 8 DECEMBER 2018
TEACHING LECTURE SYMPOSIUM
Brachytherapy Thorax high tech
14:15 - 15:15 | ROOM GARNET 212 15:15 - 16:15 | ROOM GARNET 213
Chairs: A. Ralston (Australia) and G. Kovács (Germany) Chairs: D. Verellen (Belgium) and Yasushi Nagata (Japan)
14:15 > Brachytherapy 15:15 > Immobilisation/repositioning challenges in breast cancer
Speaker: T.P. Hellebust (Norway) SP-099 Speaker: I. Chitapanarux (Thailand) SP-105
14:35 >
Challenges in implementing Image Based Adaptive Brachytherapy for 15:35 > Modern approaches in locally advanced NSCLC
Gynaecological cancers in India (Asia): Physicist Perspective Speaker: U. Ricardi (Italy) SP-106
Speaker: J. Swamidas, U. Mahantshetty (India) SP-101
15:55 > Is there still a role for surgery in early stage lung cancer?
14:55 > RTT Experience - Head and neck Brachytherapy in Indian scenario Speaker: B. Slotman (The Netherlands) SP-107
Speaker: S. Appari (India) SP-100
TEACHING LECTURE
TEACHING LECTURE Radiation carcinogenesis, prenatal, heritable
High tech technologies 16:45 - 18:00 | ROOM TOPAZ
14:15 - 15:15 | ROOM GARNET 213
Chair: Yasushi Nagata (Japan) 16:45 > Speaker: M. Joiner (USA) SP-108
14:15 > Bone marrow sparing in whole pelvic radiotherapy
Speaker: P. Franco (Italy) SP-102 PROFFERED PAPERS 4
Stimulating topics for discussion (RTT)
14:45 > Challenge with carbon ion radiotherapy for gynecological cancers
16:45 - 18:00 | ROOM GARNET 212
Speaker: T. Ohno (Japan) SP-103
Chairs: R. Chua (Australia) and M. Kamphuis (The Netherlands)
16:45 >
Can we reduce patient distress and implement patient education and
TEACHING LECTURE
support in a cost-effective way?
Clinical manifestations of normal tissue damage
G. Halkett, M. O'Connor, M. Jefford, S. Aranda, S. Merchant, N. Spry,
15:15 - 16:15 | ROOM TOPAZ R. Kane, T. Shaw, D. Youens, R. Moorin, P. Schofield (Australia) OC-109
15:15 > Speaker: E. Hau (Australia) SP-104 16:55 >
Automated atlas-based QA of clinical trial contouring to reduce
the greatest uncertainty in RT
M.J. Faustino, M.G. Jameson, J.A. Dowling, K. Cloak, M. Sidhom,
ROUNDTABLE PANEL DISCUSSION J. Martin, J. De Leon, M. Berry, D. Pryor, L.C. Holloway (Australia) OC-110
Brachytherapy
17:05 > Management of radiation dermatitis using low-level laser therapy
15:15 - 16:15 | ROOM GARNET 212
in NPC patients: A pilot study
S.W.Y. Lee, Y.W. Chan, V.W.C. Wu, C.L. Chan, V.C.W. Tam,
Moderators: G.S. Wadhawan (India) and M. Leech (Ireland)
D.L.W. Kwong (Hong Kong (SAR) China) OC-111
Panellists: S. Appari (India), S. Abdollahi (Iran Islamic Republic of),
T.P. Hellebust (Norway), V. Lancellotta (Italy),
R. Schokker (The Netherlands), J. Swamidas (India)
36 SCIENTIFIC PROGRAMME | Programme and Exhibition Guide Programme and Exhibition Guide | SCIENTIFIC PROGRAMME 37SATURDAY 8 DECEMBER 2018
SATURDAY 8 DECEMBER 2018
17:15 >
Comparison of two different atlas-based auto segmentation approaches POSTER VIEWING 4
for prostate cancer Stimulating topics for discussion (Physics)
T. Aoyama, H. Shimizu, K. Yokoi, H. Tachibana, T. Kodaira (Japan) OC-112 16:45 - 18:00 | POSTER AREA
Chairs: H. Cheng (Hong Kong (SAR) China) and S. Baggarley (Singapore)
17:25 >
Implementation of forward planned IMRT to treat breast and chest
wall patients
16:45 >
A dosimetric study of the brachytherapy treatment of carcinoma
L. Andrews, A. Williams, M. Satterthwaite, J. Donaldson, N. Whitaker,
cervix using a female pelvic phantom
L. Seddon, D. Paterson, C. Cowles (New Zealand) OC-113
M. Joan, S. Saminathan, R. Manikam (India) PV-121
17:35 > Blended learning in radiation therapy education
16:55 >
Applicator commissioning using 3T MRI for Image Guided Adaptive
B. Mudie (New Zealand) OC-114
Brachytherapy
17:45 >
An update from the 1st ESTRO-CARO-RANZCR course on Foundations
J. Swamidas, S. Paul, K. Joshi, S. Chopra, U. Mahantshetty, S. Panda,
of Leadership in Radiation Oncology K. Chauhan, D. Deshpande (India) PV-122
T. Basu (India) OC-115
17:05 >
3D printing in intracavitary head and neck, vaginal, and penis contact
Interventional Radiotherapy
V. Lancellotta, L. Tagliaferri, G. Kovacs, S. Pagano, A. Ricci, S. Saldi,
PROFFERED PAPERS 4
S. Chierchini, S. Cianetti, V. Valentini, C. Aristei (Italy) PV-123
Prostate (Clinical)
16:45 - 18:00 | ROOM GARNET 213 17:15 >
Uncertainty analyses for Monte Carlo dosimetric characterization
Chairs: V. Valentini (Italy) and Yasushi Nagata (Japan) of Co0.A86 HDR brachytherapy source
S. Abdollahi, M. Dayyani, L. Rafat Motavalli, H. Miri Hakimabad,
16:45 >
Evidence of Stage Migration to Higher Risk Prostate Cancer in E. Hoseinian Azghadi (Iran Islamic Republic of) PV-124
a Community Practice
J. Haas, C. Mendez, A. Sanchez, A. Mirza, J. Morgenstern, T. Carpenter, 17:25 >
Evaluation of a high resolution silicon detector for Quality Assurance
M. Witten, G. Demircioglu, A. Katz, J. Fain, S. Blacksburg (USA) OC-116 of VMAT
F. Matar, J. Davis, D. Wilkinson, T. Causer, I. Fuduli, G. Biasi, M. Carolan,
16:55 > Improved long-term outcomes of IMRT with androgen deprivation A. Rosenfeld, M. Petasecca (Australia) PV-125
therapy for high-risk prostate cancer
Y. Horiguchi, F. Tsukuda, Y. Hama, A. Ogata, N. Sakamoto, S. Koga (Japan) OC-117 17:35 >
MAGICA gel dosimeter: An instrument to measure the dose
enhancement factor by Bismuth nanoparticles
17:05 >
Preliminary Results of a Multicentre Study of Stereotactic Radiotherapy
S. Shoobkolaei, N. Riyahi Alam,
Boost for Prostate Cancer A. Shabestani Monfared (Iran Islamic Republic of) PV-126
J. Martin, J. Bucci, S. Arumugam, S. Gallagher, J. Smart, M. Grand,
P. Greer, S. Keats, L. Wilton, M. Sidhom, D. Pryor (Australia) OC-118 17:45 >
Impact of radiotherapy on ovarian function in ovarian transposition
of cervical cancer patients
17:15 > BIT-ART: Brachytherapy, IMRT, Tomotherapy for prostate cancer
S. Lu, L. Yin, J. Wang, W. Hu, G. Ke (China) PV-127
Advanced Radiation Therapy
L. Tagliaferri, A. D'Aviero, A.R. Alitto, V. Frascino, F. Catucci, V. Lancellotta,
C. Staackmann, C. Aristei, V. Valentini, G. Mantini, G. Kovács (Italy) OC-119
17:25 >
International validation of the EORTC QLQ-PRT20 module for
symptoms relating to radiation proctitis
G. Halkett, C.A. Wigley, S. Aoun, M. Portaluri, F. Tramacere, L. Livi,
B. Detti, S. Arcangeli, J.A. Lund, A. Kristensen, N. McFadden, A. Grun,
E. Greimel, N. Spry (Australia) OC-120
38 SCIENTIFIC PROGRAMME | Programme and Exhibition Guide Programme and Exhibition Guide | SCIENTIFIC PROGRAMME 39Sunday 9 December 2018
SUNDAY 9 DECEMBER 2018
SUNDAY 9 DECEMBER 2018
M. Mel (Cambodia)
M. Coffey (Ireland)
E.H. Zubizarreta (Austria)
A. Ralston (Australia)
JOINT INTERDISCIPLINARY FORUM
ROUND TABLE/DEBATE
Collaborations for improving access & practice of radiation oncology:
Advocacy initiatives and priorities in the global setting
advocacy and education 10:45 - 12:15 | ROOM GARNET 213
10:45 > HERO /EU perspective
SYMPOSIUM
Y. Lievens (Belgium) SP-133
Setting the scene: advocacy and education
08:15 - 09:15 | ROOM GARNET 213 10:53 > Global task force/GIRO
Chair: Natalka Suchowerska (Australia) and M. Leech (Ireland) D. Rodin (Canada) SP-134
08:15 >
APROSIG : Knowledge exchange between Australasian and Asia-Pacific 11:01 > Advocacy initiatives and priorities in the global setting
radiotherapy professionals S. Chopra (India) SP-135
Speaker: M.L. Yap, A. Oar, E. Esguerra, S. Corde Tehei, S. Downes, 11:09 > FARO Initiatives in Asia: Towards Better Radiotherapy Services
G. Grogan, S. Heng, G. Newman, C. Opie, K. Rogl, N. Shelton, S. Gondhowiardjo (Indonesia) SP-136
I. Ward (Australia) SP-128
11:17 > IAEA
08:27 > National Cancer Center of Cambodia - Establishing Modern E.H. Zubizarreta (Austria) SP-137
Radiotherapy and Comprehensive Cancer Care
Speaker: M. Mel, S. Eav, P. Bunpa, O. Lim (Cambodia) SP-129
08:39 > Collaboration with ESTRO School/built up TTT course in India PLENARY SESSION
and simultaneous change of practice ESTRO meets ASIA: a bridge towards future collaboration
Speaker: J. Swamidas (India) SP-130 13:30 - 14:30 | ROOM GARNET 213
08:51 > Postgraduate education of Radiation Oncology professionals in Europe
Speaker: J. Eriksen (Denmark) SP-131 CLOSING CEREMONY
09:03 > The role of the ESTRO and the IAEA
Closing ceremony
14:30 - 15:00 | ROOM GARNET 213
Speaker: M. Coffey (Ireland) SP-132
ROUND TABLE/DEBATE
Advancing education for RO professionals
09:15 - 10:15 | ROOM GARNET 213
Moderator: S. Turner (Australia)
Panellists:
J.G. Eriksen (Denmark)
S. Wong (Singapore)
40 SCIENTIFIC PROGRAMME | Programme and Exhibition Guide Programme and Exhibition Guide | SCIENTIFIC PROGRAMME 41NOTES NOTES
POSTERS
Posters 44
42 43Posters
POSTERS
POSTERS
>
Response evaluation of concurrent chemotherapy and conformal
radiotherapy in hypopharynx carcinoma
B. Mir Khan (Pakistan) PO-146
>
Utility of MRI in determining treatment response and local recurrence
POSTER in nasopharyngeal cancer (NPC)
Clinical: Head and Neck T. Meng, J. Tey, H. Asim, T. Cheo (Singapore) PO-147
>
Radiation-induced nasopharyngeal ulcers after IMRT in primary NPC >
Benefits of Elective Tracheostomy in head and neck cancer patients
patients: a dose-volume analysis with laryngeal obstruction
Y. Li, T. Xu, X. Lu, C. Hu (China) PO-138 K.K. Br (India) PO-148
>
Compare two Induction Chemotherapys with Concurrent >
Mucolytic N-Acetylcysteine vs Placebo Rinses for Mucositis during
Chemoradiotherapy in Nasopharyngeal Carcinoma Head and Neck Chemoradiotherapy
Z. Zeng, L. Liu, R. Yan, L. Tu, Y. Wang, P. Chen (China) PO-139 J.C. Rwigema, T. Sio, M. Blanchard, P. Novotny, S. Patel, L. Pederson,
M. Gamez, G. Seeger, J. Martenson, Y. Grover, R. Foote, R. Miller,
>
Induction chemo followed by rt vs. Surgery followed by ccrt in locally M. Halyard (USA) PO-149
advanced scc of oral cavity
S.H. A. Ali, J. Mallick, A.H. Lakhna (Pakistan) PO-140 >
Dosimetric Predictors of Physician and Patient Rated-Xerostomia
After IMRT in Nasopharyngeal Cancer
> Outcomes of Definitive Chemoradiation for Nasopharyngeal Cancer: K. Sommat, W.S. Ong, A. Hussain, N.L.F. Yit, J.B.K. Khoo, Y.L. Soong,
A Single Institution Experience. K.W. Fong, T.W.K. Tan, J.T.S. Wee (Singapore) PO-150
K. Venkatesan, V. Anand, R. Bajpai, V. Babu, A. Kolse, S. Deshpande,
S. Naidu, S. Almel, M. Shaikh, M. Lala, S. Pradhan, M. Kirtane, >
Robotic fractionated stereotactic radiotherapy in recurrent head and
A. Kapadia (India) PO-141 neck cancers: Clinical outcomes
S. Mishra, T. Kataria, S. Goyal, R. Thiyagarajan, D. Gupta, S.S. Bisht,
>
Role of Adjuvant Radiotherapy in the Elderly with Localized Squamous S. Banerjee, K. Narang, R. Ratan (India) PO-151
Cell Carcinoma of Oral Tongue
F.Y. Lin, T.H. Chang, M.T. Liu, C.P. Pi, C.C. Huang, T.W. Chou, >
Frequency of anxiety & depression among patients undergoing
J.B. Lin (Taiwan) PO-142 radiotherapy for head and neck cancer
M. Uddin Karim, A.N. Abbasi, B.M. Qureshi, N. Ali, A. Hafiz,
> How do we use neck node data? B.M. Khaskheli, M.H. Aga, Y. Ahmed, F. Shaukat, M.A. Mansha (Pakistan) PO-152
ABSTRACT WITHDRAWN PO-143
>
Two Phase IMRT vs SIB IMRT in locally advanced head and neck
>
Clinical outcomes and dose-volume predictors of hypothyroidism in cancers with concurrent chemotherapy
head and neck malignancies S. Hunugundmath, S. Basu, B. Zade, V.K. Sathiyanarayanan, A. Nirhali,
V. Pareek, R. Bhalavat, M. Chandra, L. Nellore, K. George, D. Borade, P. M, M. Munshi (India) PO-153
K. Kalariya, R. Navaneeth, Z. Moosa, A. Srivastava, A. Kapoor,
D. Kawale, P. Bauskar (India) PO-144 >
Treatment Outcomes and Patterns of Failure in in Major Salivary Gland
Salivary Duct Carcinomas
>
HDR Interstitial brachytherapy in Recurrent head and neck cancer:
D.S. Lee, M.K. Kang, K.M. Kang, K.C. Keum, Y.S. Kim, J.H. Kim, J.H. Kim,
An effective treatment modality S.H. Moon, Y.T. Oh, H.G. Wu, C.G. Lee, K.H. Cho (Korea Republic of) PO-154
V. Pareek, R. Bhalavat, M. Chandra (India) PO-145
44 POSTERS | Programme and Exhibition Guide Programme and Exhibition Guide | POSTERS 45POSTERS
POSTERS
>
Planning Risk Volume PRV quantification of spinal cord & canal doses POSTER
in head&neck cancer radiation Clinical: CNS
A. Waheed (Pakistan) PO-155
>
Correlation of PFS with RANO criteria in primary GBM patients
>
Results of surgery for early tongue cancer and effects of adjuvant RT in treated by chemoradiotherapy
patients with risk features A. Mukherjee, N. Kumar, S. Dhunganama (India) PO-163
C. Hao-Shen, L. Jin-Ching, L. Shih-An (Taiwan) PO-156
>
Management of CNS germ cell tumors - Decreasing treatment
>
Value of 18F-FDG-PET/CT and 131I-WBS in the detection of heterogeneity in developing countries
differentiated thyroid cancer progression R. Tonse, R. Jalali (India) PO-164
T. Geliashvili, A. Vazhenin, N. Afanasieva, E. Vasil’eva (Russian Federation) PO-157
>
Hippocampal avoidance in WBRT for Metastases – Neurocognitive
>
Clinical outcome of head and neck cancer treated with radical IMRT: and Dosimetric Assessment
An institutional report V. Pareek, R. Bhalavat, M. Chandra, L. Nellore, K. George (India) PO-165
A.K. Patidar, P.H. Hirapara, N.A. Patel, D.M. Murthy, A. Kulshreshtha,
S. Nandeshwar (India) PO-158 > Impact of psychological support during radiotherapy in patients with b
rain tumor: final report
>
Weight loss in nasopharyngeal cancer mainly to be associated with L. Dinapoli, S. Chiesa, R. Gatta, F. Beghella Bartoli, N. Dinapoli,
pre-treatment dental extraction S. Bracci, A. Tenore, C. Mazzarella, G. Sabatino, S. Luzi, A. Olivi,
S. Benkhaled, T. Dragan, S. Beauvois, A. De Caluwe, F. Charlier, V. Valentini, M. Balducci (Italy) PO-166
D. Van Gestel (Belgium) PO-159
>
Clinical outcome of high-grade glioma in a tertiary cancer hospital
>
Acute skin toxicity assessment among head and neck cancer patients of Bangladesh: 1 year experience
treated with VMAT A.R. Chowdhury, M.R. Sharif, M.S.S. Alam, N. Rukhsana,
R. Ahmad, N. Ismail, M.N. Norfadilah, N.A. Yahya (Malaysia) PO-160 M.M.S. Hossain, L. Nahar, M.M. Huda, P.A. Banu (Bangladesh) PO-167
>
Radiotherapy Dose Escalation in Primary Treatment of NPC: >
Moderate hypofractionated accelerated radiotherapy using tomotherapy
A Sytematic Review and Meta-analysis for patients with glioblastoma
L. Co (Philippines) PO-161 Y.I. Kim, C. Moon-June, K. Jun-Sang, K. Ki-Hwan,
K. Jin-E (Korea Republic of) PO-168
>
Outcomes with Local Therapy for mNPC at Diagnosis: Experience
from a Tertiary Center in a LMIC >
Comparative Dosimetric Evaluation of 3D-CRT versus VMAT For
K.K. Yu (Philippines) PO-162 Postoperative Pituitary Adenoma
S.S. Nanda, M. Rastogi, A.K. Gandhi, K. Sahni, R. Khurana, R. Hadi,
S.P. Mishra, A. Srivastava, H.B. Singh, S. Rath, P.C. Rai,
M.L.B. Bhatt (India) PO-169
>
Does low junction Craniospinal irradiation (CSI) treated with VMAT
improves organs at risk dose .
P. Chaudhari (India) PO-170
46 POSTERS | Programme and Exhibition Guide Programme and Exhibition Guide | POSTERS 47POSTERS
POSTERS
>
Clinical outcome of hypofractionated stereotactic radiotherapy > A Simplified Three-Isocenter VMAT for Craniospinal Irradiation
for inoperable skull base meningioma I. Takahashi, Y. Adachi, N. Imano, Y. Takeuchi, I. Nishibuchi, K. Miki,
D. Takafumi Yamano, D. Takeo Takahashi, D. Keiichiro Nishimura, A. Saito, T. Kimura, Y. Murakami, Y. Nagata (Japan) PO-178
D. Kana Washizu, D. Rikana Soda, D. Hiromasa Kurosaki,
D. Nobuko Utsumi, D. Munefumi Shimbo, D. Shogo Hatanaka,
D. Masatsugu Haryu (Japan) PO-171 POSTER
Clinical: Breast
>
Prospective neurocognitive and oncological outcomes in newly-
diagnosed primary CNS lymphoma patients >
VMAT applied to SBBC radiotherapy: dosimetric study on DIBH
S.Y. Lin, C. Chi-Cheng, T. Din-Li, P. Ping-Ching, S. Yi-Liang (Taiwan) PO-172 versus FB set up.
D. Gaudino, S. Cima, M. Frapolli, D. Daniele, B. Muoio, G.A. Pesce,
> PREdiction Models in Stereotactic External Radiotherapy for brain F. Martucci, N.C. Azinwi, D. Bosetti, L. Bellesi, M. Casiraghi, M.A. Piliero,
lesions: PRE.M.I.S.E. project F. Pupillo, S. Presilla, A. Richetti, M.C. Valli (Switzerland) PO-179
S. Longo, S. Chiesa, F. Bianciardi, B. Tolu, B. Nardiello, F. Rea, G. Stimato,
L. Capone, F. Cellini, J. Lenkowicz, M. Massaccesi, G. Minniti, >
Heart dose difference for prone left breast radiation therapy on
A. Pacchiarotti, V. Lanzotti, L. Boldrini, M. Balducci, A. Damiani, Elekta Synergy and Varian 21iX
V. Valentini, P. Gentile (Italy) PO-173 B. Naydich, K. Feng, P. Hopko, L. Shaw, K. Settle, S. Parikh (USA) PO-180
>
GLIFA Project: Glioblastoma radiomics Features Analysis. >
Hypofractionated radiotherapy is feasible in patients undergoing
A prospective multi-centric study breast conserving surgery
S. Chiesa, F. Beghella Bartoli, M. Lupattelli, D. Cusumano, I. Palumbo, S. Agrawal (India) PO-181
R. Barone, A. Rongoni, R. Tarducci, R. Russo, P. Floridi, D. Nicola,
S. Longo, L. Boldrini, M. Balducci, V. Valentini, C. Aristei (Italy) PO-174 >
Clinical outcomes in patients with ER positive, HER2 negative locally
advanced breast cancer
N. Nakajima, Y. Kumai, I. Serizawa, Y. Yoshioka, M. Oguchi (Japan) PO-182
POSTER
Clinical: Haematology >
Bone Metastases and Prognosis in Newly Diagnosed Breast Cancer:
A Population-Based Study
>
Prognostic role of PET/CT in DLBCL - Assessment of Deauville criteria J. Zhang, H. Gong, M. Li, B. Li (China) PO-183
and SUV max
V. Pareek, C. Bakshi, R. Bhalavat, M. Chandra (India) PO-175 >
Quality of Life Assessment comparison between APBI and WBI
in BCS – Single Institute Experience
>
Outcome of diffuse large B-cell lymphoma treated with Radiotherapy – V. Pareek, R. Bhalavat, M. Chandra, N. Bhambhani, C. Bakshi, L. Nellore,
Single institution experience K. George, D. Borade (India) PO-184
I.C. Rajasooriyar, L.C. Wong, J. Tey, K.M. Lee, I. Tham,
B. Vellayapan (Sri Lanka) PO-176 >
IMN irradiation improves disease-free survival and locoregional
control in breast cancer patients
>
Assessment of Quality of Life in Elderly and young DLBCL: X. Wang (China) PO-185
Risk Parameters and clinical outcomes
V. Pareek, V.K. Pareek, R. Bhalavat, R. Pareek, M. Chandra, C. Bakshi, >
Hypofractionation in breast cancer-A Retrospective study in a Tribal
L. Nellore, K. George, K. Kalariya, N. Reddy, Z. Moosa, A. Srivastava, based rural medical college
A. Kapoor, D. Kawale, V. Masurkar, N. Bhambhani (India) PO-177 S. Acharyya, B. Dr. Bidisha Ghosh (India) PO-186
48 POSTERS | Programme and Exhibition Guide Programme and Exhibition Guide | POSTERS 49POSTERS
POSTERS
>
Hypofractionated radiotherapy in breast cancer: Experience from a >
Evaluation of Target volume coverage by Conventional vs RTOG
cancer center of Bangladesh contouring based plans in breast cancer
A.R. Chowdhury, N. Rukhsana, M. Rahman, S.R. Malik, P. Verma, K. Sahni, M. Rastogi, S.S. Nanda, R. Khurana, R. Hadi,
P.A. Banu (Bangladesh) PO-187 S. Sapru, A.K. Gandhi, S. Farzana, A. Shrivastava, S.P. Mishra, A. Bharti,
N. Agarwal, A.P. Singh, S. Das, S. Manna (India) PO-196
> Hypofractionated Radiotherapy for Breast Cancer: An Indian experience
A. Sen, S. Mallik, J. Goswami, S. Das, M. Mondal, S. Sheet, S. Ferdinand, >
Dosimetric parameters and acute skin toxicity association
B. Pal, S. Das, S. Palit, P. Sarkar, S. Mitra, J. Koley, S. Dutta, in whole breast radiotherapy
M. Chakraborty, S. Mondal, J. Basak, A. Dinda, P. Dutta (India) PO-188 J. Das, G. Karunanidhi, S. Kandasamy, C. Ramalingam (India) PO-197
>
Deep inspiration breath hold (DIBH) for left breast cancer: >
Dosimetric study of left-sided breast with IMN irradiation for BCT
a dosimetric comparison patients using IMRT and VMAT
M.I.M. Lei, H. Hu, G.L. Xiao (Macau) PO-189 L.Y. Yau, C.L. Law, K.Y. Lam, Y.Y.M. Law (Hong Kong (SAR) China) PO-198
>
Salvage Radiotherapy with a new radio-sensitizer (KORTUC) >
Cardiac dose reduction with DIBH technique in left breast cancer
for 2 breast cancer cases patients- An institutional study
S. Obata, Y. Ogihara, T. Takeda, S. Miyagi, Y. Ohta, T. Kan, S. Kanegae, D. Borade, S.K. Shrivastava, S. De, S. Choudhari, A. Churi, A. Bargundi,
Y. Inoue, A. Kuroiwa, K. Inoue, K. Watanabe, H. Orita, A. Arioka (Japan) PO-190 S. Nair (India) PO-199
>
Parameters defying the cardiac dose reduction benefit of DIBH in left
>
Cardiac and lung doses for breast cancer patients with free breathing a
breast cancer radiotherapy
nd breath hold technique
U. Saxena, A. Bhange, P. Ganeshan, A. Karuppusamy, T. Basu, N. Bhaskar,
M.R.U. Nabi, S. Poudel, K.R. Mani (Bangladesh) PO-191
S. Vangipuram, D. Sen, S. Maurya, S. Thacheril, S. Sebastian (India) PO-200
>
To compare two boost protocols of hypofractionated RT with VMAT
in patients with breast cancer
POSTER
S. Gupta, B.S. Yadav, D. Dahiya, A. Oinam (India) PO-192
Clinical: Lung
>
Prognostic factors in locally advanced breast cancer with HER2+/HR-
>
A Prospective Study Comparing CCRT Using Paclitaxel-Carboplatin
with NAC followed by PMRT.
and Etoposide-Cisplatin In NSCLC
Y. Kumai, N. Nakajima, H. Inoda, Y. Yoshioka, M. Oguchi (Japan) PO-193
S. G Y (India) PO-201
>
Assessment of cosmesis, quality of life in patients who have undergone
>
Concomitant chemoradiotherapy vs accelerated rt in locally advanced
breast conservation therapy
non-small cell lung cancers
D.C. Ramalingam, D.G. Karunanidhi, D.K. Dharanipragada,
S. Rana (India) PO-202
D.P. Penumadu, D.J. Das (India) PO-194
>
A Novel Transfer Learning Framework for IGTV Definition
>
Voluntary inspiration breath-hold technique in left-sided breast cancer from 4DCT of Lung Cancer Patients
radiation therapy in Asian X. Li, Q. Deng, L. Zhang, T. Niu, Y. Kuang, S. Wu, S. Ma (China) PO-203
W.L. Chan, M. Lo, J. Kong, M. Szeto, S. Ng, A. Chan, T. Lam,
M. Luk (Hong Kong (SAR) China) PO-195 >
Exploring the predictive value of feature changes in PET radiotherapy o
f NSCLC patients
C. Ma (China) PO-204
50 POSTERS | Programme and Exhibition Guide Programme and Exhibition Guide | POSTERS 51You can also read
